ArticleTranslational lung cancer research2021

Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab.

Amparo Sánchez-Gastaldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.